165 related articles for article (PubMed ID: 24952512)
1. Genetic polymorphism of metallothionein 2A and risk of laryngeal cancer in a Polish population.
Starska K; Krześlak A; Forma E; Olszewski J; Lewy-Trenda I; Osuch-Wójcikiewicz E; Bryś M
Med Oncol; 2014 Jul; 31(7):75. PubMed ID: 24952512
[TBL] [Abstract][Full Text] [Related]
2. Metallothionein 2A core promoter region genetic polymorphism and its impact on the risk, tumor behavior, and recurrences of sinonasal inverted papilloma (Schneiderian papilloma).
Starska K; Bryś M; Forma E; Olszewski J; Pietkiewicz P; Lewy-Trenda I; Stasikowska-Kanicka O; Danilewicz M; Krześlak A
Tumour Biol; 2015 Nov; 36(11):8559-71. PubMed ID: 26036762
[TBL] [Abstract][Full Text] [Related]
3. Metallothionein 2A genetic polymorphisms and risk of ductal breast cancer.
Krześlak A; Forma E; Jóźwiak P; Szymczyk A; Smolarz B; Romanowicz-Makowska H; Różański W; Bryś M
Clin Exp Med; 2014 Feb; 14(1):107-13. PubMed ID: 23053628
[TBL] [Abstract][Full Text] [Related]
4. Metallothionein 2A genetic polymorphisms and risk of prostate cancer in a Polish population.
Forma E; Krzeslak A; Wilkosz J; Jozwiak P; Szymczyk A; Rozanski W; Brys M
Cancer Genet; 2012 Sep; 205(9):432-5. PubMed ID: 22824183
[TBL] [Abstract][Full Text] [Related]
5. The c.*229C > T gene polymorphism in 3'UTR region of the topoisomerase IIβ binding protein 1 gene and LOH in BRCA1/2 regions and their effect on the risk and progression of human laryngeal carcinoma.
Starska K; Forma E; Nowacka-Zawisza M; Lewy-Trenda I; Ciesielski P; Pietruszewska W; Skóra M; Bryś M
Tumour Biol; 2016 Apr; 37(4):4541-57. PubMed ID: 26503213
[TBL] [Abstract][Full Text] [Related]
6. The -5 A/G single-nucleotide polymorphism in the core promoter region of MT2A and its effect on allele-specific gene expression and Cd, Zn and Cu levels in laryngeal cancer.
Starska K; Krześlak A; Forma E; Olszewski J; Morawiec-Sztandera A; Aleksandrowicz P; Lewy-Trenda I; Bryś M
Toxicol Appl Pharmacol; 2014 Oct; 280(2):256-63. PubMed ID: 25157674
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms (rs10636 and rs28366003) in metallothionein 2A increase breast cancer risk in Chinese Han population.
Liu D; Wang M; Tian T; Wang XJ; Kang HF; Jin TB; Zhang SQ; Guan HT; Yang PT; Liu K; Liu XH; Xu P; Zheng Y; Dai ZJ
Aging (Albany NY); 2017 Feb; 9(2):547-555. PubMed ID: 28228606
[TBL] [Abstract][Full Text] [Related]
8. Metallothionein 2A gene polymorphisms in relation to diseases and trace element levels in humans.
Sekovanić A; Jurasović J; Piasek M
Arh Hig Rada Toksikol; 2020 Mar; 71(1):27-47. PubMed ID: 32597135
[TBL] [Abstract][Full Text] [Related]
9. The effect of metallothionein 2A core promoter region single-nucleotide polymorphism on accumulation of toxic metals in sinonasal inverted papilloma tissues.
Starska K; Bryś M; Forma E; Olszewski J; Pietkiewicz P; Lewy-Trenda I; Danilewicz M; Krześlak A
Toxicol Appl Pharmacol; 2015 Jun; 285(3):187-97. PubMed ID: 25900616
[TBL] [Abstract][Full Text] [Related]
10. Quantitative assessment of the association of polymorphisms in the metallothionein 2A gene with cancer risk.
Wang J; Huang P; Zhao W; Ren W; Ai L; Wu L
J Int Med Res; 2020 Aug; 48(8):300060520947937. PubMed ID: 32809904
[TBL] [Abstract][Full Text] [Related]
11. METALLOTHIONEIN-2A (RS1610216&RS28366003) GENE POLYMORPHISMS AND THE RISK OF STOMACH ADENOCARCINOMA.
Shokrzadeh M; Mohammadpour A; Ghassemi-Barghi N; Hoseini V; Abediankenari S; Tabari YS
Arq Gastroenterol; 2019; 56(4):367-371. PubMed ID: 31721970
[TBL] [Abstract][Full Text] [Related]
12. Effect of metallothionein 2A gene polymorphism on allele-specific gene expression and metal content in prostate cancer.
Krześlak A; Forma E; Chwatko G; Jóźwiak P; Szymczyk A; Wilkosz J; Różański W; Bryś M
Toxicol Appl Pharmacol; 2013 May; 268(3):278-85. PubMed ID: 23466427
[TBL] [Abstract][Full Text] [Related]
13. Metallothionein polymorphisms in a Northern Spanish population with neovascular and dry forms of age-related macular degeneration.
García M; Álvarez L; Fernández Á; González-Iglesias H; Escribano J; Fernández-Vega B; Villota E; Fernández-Vega Cueto L; Fernández-Vega Á; Coca-Prados M
Ophthalmic Genet; 2017; 38(5):451-458. PubMed ID: 28635422
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation at a metallothionein 2A promoter single-nucleotide polymorphism in white and black females in Midwestern United States.
McElroy JA; Bryda EC; McKay SD; Schnabel RD; Taylor JF
J Toxicol Environ Health A; 2010; 73(19):1283-7. PubMed ID: 20711930
[TBL] [Abstract][Full Text] [Related]
15. Distributions of interleukin-6 (IL-6) promoter and metallothionein 2A (MT2A) core promoter region gene polymorphisms and their associations with aging in Turkish population.
Kayaaltı Z; Sahiner L; Durakoğlugil ME; Söylemezoğlu T
Arch Gerontol Geriatr; 2011; 53(3):354-8. PubMed ID: 21277639
[TBL] [Abstract][Full Text] [Related]
16. Association of metallothionein 2A rs10636 with low mean corpuscular volume (MCV), low mean corpuscular haemoglobin (MCH) in healthy Taiwanese.
Chen RF; Chen PM; Pan CS; Huang CC; Chiang EI
Sci Rep; 2023 Jan; 13(1):1292. PubMed ID: 36690679
[TBL] [Abstract][Full Text] [Related]
17. The association of the blood lead level and serum lipid concentrations may be modified by the genetic combination of the metallothionein 2A polymorphisms rs10636 GC and rs28366003 AA.
Yang CC; Chuang CS; Lin CI; Wang CL; Huang YC; Chuang HY
J Clin Lipidol; 2017; 11(1):234-241. PubMed ID: 28391890
[TBL] [Abstract][Full Text] [Related]
18. Associations of Polymorphisms Localized in the 3'UTR Regions of the
Insodaite R; Smalinskiene A; Liutkevicius V; Ulozas V; Poceviciute R; Bielevicius A; Kucinskas L
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828284
[TBL] [Abstract][Full Text] [Related]
19. Topoisomerase IIβ binding protein 1 c.*229C>T (rs115160714) gene polymorphism and endometrial cancer risk.
Forma E; Wójcik-Krowiranda K; Jóźwiak P; Szymczyk A; Bieńkiewicz A; Bryś M; Krześlak A
Pathol Oncol Res; 2014 Jul; 20(3):597-602. PubMed ID: 24346708
[TBL] [Abstract][Full Text] [Related]
20. Metallothionein MT2A A-5G Polymorphism as a Risk Factor for Chronic Kidney Disease and Diabetes: Cross-Sectional and Cohort Studies.
Hattori Y; Naito M; Satoh M; Nakatochi M; Naito H; Kato M; Takagi S; Matsunaga T; Seiki T; Sasakabe T; Suma S; Kawai S; Okada R; Hishida A; Hamajima N; Wakai K
Toxicol Sci; 2016 Jul; 152(1):181-93. PubMed ID: 27122239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
